Benitec Biopharma Inc. (BNTC) Financials

BNTC Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 182.6 million 5.6 million
March 31, 2026 187.0 million 3.7 million
Dec. 31, 2025 190.7 million 3.3 million
Sept. 30, 2025 96.0 million 2.4 million

BNTC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -5.0 million 6.3 million
March 31, 2026 -4.9 million 7.6 million
Dec. 31, 2025 -3.8 million 7.4 million
Sept. 30, 2025 -3.4 million 5.2 million

BNTC Net Income

No data available :(

BNTC Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 180.0 million - 762000
March 31, 2026 184.8 million 394000 482000
Dec. 31, 2025 188.8 million - 987000
Sept. 30, 2025 94.5 million - 817000

BNTC Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 46.6 million
March 31, 2026 49.4 million
Dec. 31, 2025 46.0 million
Sept. 30, 2025 41.5 million

BNTC Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 79000 9.6 million 6.5 million -
March 31, 2026 16042 6.3 million 7.3 million -
Dec. 31, 2025 11000 5.8 million 7.5 million -
Sept. 30, 2025 - 3.4 million 6.4 million -

BNTC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 -833044 124000
March 31, 2026 - 119000
Dec. 31, 2025 - 120000
Sept. 30, 2025 - 118000

BNTC Revenue by Segment
Graph available only for paid members. Upgrade to see it.

BNTC

Price: $8.63

52 week price:
8.52
16.76

Earnings Per Share: -0.98 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 208500

Ebitda: -11.8 million

Market Capitalization: 319.3 million

Links: